The importance of tight glycaemic control was underscored by the landmark 1993 ‘Diabetes Control and Complications Trial’, which demonstrated that intensive insulin therapy significantly reduced the risk of long-term microvascular complications [2]. This evidence concerns the gene INS and diabetes mellitus.